NASDAQ: STROSutro Biopharma Inc Stock Ownership - Who owns Sutro Biopharma?
Insider buying vs selling
Have Sutro Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jane Chung | Chief Executive Officer | 2025-12-12 | 894 | $8.02 | $7.17kSell |
| Hanspeter Gerber | CHIEF SCIENTIFIC OFFICER | 2025-10-15 | 17,000 | $0.80 | $13.60kBuy |
| Connie Matsui | Director | 2025-10-15 | 50,000 | $0.80 | $39.95kBuy |
| Gregory K. Chow | CFO | 2025-10-15 | 19,750 | $0.81 | $16.00kBuy |
| Jane Chung | Chief Executive Officer | 2025-10-15 | 12,500 | $0.80 | $10.01kBuy |
| David Pauling | Chief Admin. Ofcr. GC | 2025-10-15 | 12,504 | $0.80 | $9.99kBuy |
| Hanspeter Gerber | CHIEF SCIENTIFIC OFFICER | 2025-09-18 | 13,417 | $0.90 | $12.08kSell |
| Jane Chung | Chief Executive Officer | 2025-08-09 | 6,708 | $0.80 | $5.37kSell |
| Barbara Leyman | Chief Business Officer | 2025-07-08 | 8,944 | $0.78 | $6.98kSell |
| Edward C. Albini | CFO AND SECRETARY | 2025-05-15 | 15,995 | $0.88 | $14.08kSell |
STRO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when STRO insiders and whales buy or sell their stock.
STRO Shareholders
What type of owners hold Sutro Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Suvretta Capital Management LLC | 76.21% | 6,488,324 | $96.61M | Institution |
| Kynam Capital Management LP | 59.76% | 5,088,099 | $75.76M | Institution |
| Millennium Management LLC | 53.14% | 4,524,350 | $67.37M | Institution |
| Vanguard Group Inc | 43.26% | 3,682,986 | $54.84M | Institution |
| Acadian Asset Management LLC | 39.81% | 3,389,322 | $50.47M | Institution |
| Velan Capital Investment Management LP | 36.65% | 3,120,000 | $46.46M | Institution |
| Tang Capital Management LLC | 33.23% | 2,828,717 | $42.12M | Institution |
| Merck Co Inc | 31.99% | 2,723,509 | $40.55M | Institution |
| Merck Co Inc | 31.99% | 2,723,509 | $40.55M | Insider |
| Vestal Point Capital LP | 30.54% | 2,600,000 | $38.71M | Institution |
STRO vs Biotech Stocks
Sutro Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.